disease

Learn About Latest Discoveries in Alzheimer’s Disease on CME Webcast

by

OSUWexnerbloglogo2014 Learn About Latest Discoveries in Alzheimer’s Disease on CME Webcast. 120 years ago, when Dr. Alzheimer first started taking care of Auguste Deter, there was no treatment for her condition. But now, medical research has brought us new treatments with hope for some patients who previously had no hope. On this CME webcast, we are going to hear about some of this research and some of these new treatments. We’re pleased to welcome Assistant Professor of Neurology, Dr. Rawan Tarawneh.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: Understand the pathology of Alzheimer disease, including the clinical and pathological heterogeneity and the importance of biomarkers for an accurate diagnosis; Learn about the new FDA-approved anti-amyloid agent aducanumab (approved June 2021).

You’ll also learn about the following:

  • Etiology of Alzheimer’s Disease
  • Alzheimer’s Disease treatments
  • Concerns regarding aducanumab
  • Identifying patients with Alzheimer’s disease in the primary care office
  • Diet and lifestyle measures
  • Managing insomnia

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Webcast Helps Physicians Learn About Ocular Complications of Systemic Disease

by

OSUWexnerbloglogo2014 Webcast Helps Physicians Learn About Ocular Complications of Systemic Disease. It has been said that the eyes are the windows to the soul. That may or may not be true but the eyes can be the windows to disease. Sometimes, it is the ocular findings that are the first clue to an underlying systemic disease. Other times, a known systemic disease may alert the physician about the risks of important ocular complications. The ophthalmoscope allows you to examine structures you can’t otherwise see. For example, the retinal arteries are the only arteries that are easily visible non-invasively. Today on MedNet21, we’re going to see how the eye can be affected by many common systemic diseases. My guest is Assistant Professor of Ophthalmology, Dr. Carla Ford.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: discuss ocular findings
of common systemic diseases; and provide a brief overview of treatment options of ocular complications of systemic diseases.

You’ll also learn about the following:

  • Common systemic diseases affecting the eye
  • Central retinal vein occlusion
  • Migraine and the eye
  • Candidemia
  • HIV and the eye

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webast Teaches On Chronic Kidney Disease

by

OSUWexnerbloglogo2014 CME Webast Teaches On Chronic Kidney Disease. Now, dialysis has become so commonplace that we now consider it to be a routine treatment in nearly every hospital in the country. But more importantly, we now have treatments that can hold kidney failure in check and often prevent the need for dialysis. Today on MedNet, we are going to take a look at some of these new developments in the management of chronic kidney disease. I’m please to introduce today’s guest. Dr. Khaled Boubes is nephrologist and Assistant Professor of Internal Medicine at the Ohio State University.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: recognize the prevalence and importance of CKD; and realize the importance and effectiveness of SGLT2-inhibitors in halting the progression of CKD.

You’ll also learn about the following:

  • Causes of chronic kidney disease
  • New treatments for chronic kidney disease
  • Diet and chronic kidney disease
  • Blood pressure management in chronic kidney disease
  • Anti-hypertensive medication selection in chronic kidney disease
  • Acute dialysis indications
  • Chronic dialysis indications
  • Options for dialysis

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line Education Teaches Physicians About Multiple Sclerosis

by

OSUWexnerbloglogo2014 On-line Education Teaches Physicians About Multiple Sclerosis. Over the past 25 years, there have been dramatic new developments in how we treat multiple sclerosis and this is giving hope to patients who on the past had very few options. Here today to bring us up to date on the latest developments in multiple sclerosis is the Chairman of the OSU Department of Neurology, Dr. Benjamin Segal.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: LEARN about the typicalclinical course of multiple sclerosis and disease modifying treatments; and LEARN about our current understanding of the pathogenesis of MS.

You’ll also learn about the following:

  • Common signs and symptoms of multiple sclerosis
  • Current concepts in multiple sclerosis treatment

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line Education Teaches Physicians About Interstitial Lung Disease

by

OSUWexnerbloglogo2014 On-line Education Teaches Physicians About Interstitial Lung Disease. Once each year, I exercise moderator’s privileges and serve as both host and presenter and so today, I’m going to be talking about a topic that is important to me, namely interstitial lung disease.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: IDENTIFY patients with undiagnosed interstitial lung disease based on clinical, radiographic, and pulmonary function test presentations; DISTINGUISH idiopathic pulmonary fibrosis from other common interstitial diseases based on radiographic and pathologic findings; and DESCRIBE the initial management of common interstitial lung diseases including idiopathic pulmonary fibrosis, non-specific interstitial pneumonitis,
hypersensitivity pneumonitis, and sarcoidosis.

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.